[
  {
    "ts": "2025-10-14T22:13:46+00:00",
    "headline": "DexCom (DXCM): Valuation in Focus After Q2 Revenue Beat and Cautious Outlook on Sector Tensions",
    "summary": "DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade tensions have also impacted sentiment. See our latest analysis for DexCom. DexCom’s share price has lost some momentum lately, reflecting both sector-wide pressure from US-China trade uncertainty and a cautious full-year outlook that overshadowed its quarterly revenue beat. While the 1-year total...",
    "url": "https://finance.yahoo.com/news/dexcom-dxcm-valuation-focus-q2-221346549.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5e281b2d-b485-39ad-aab8-04b9779119f3",
      "content": {
        "id": "5e281b2d-b485-39ad-aab8-04b9779119f3",
        "contentType": "STORY",
        "title": "DexCom (DXCM): Valuation in Focus After Q2 Revenue Beat and Cautious Outlook on Sector Tensions",
        "description": "",
        "summary": "DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade tensions have also impacted sentiment. See our latest analysis for DexCom. DexCom’s share price has lost some momentum lately, reflecting both sector-wide pressure from US-China trade uncertainty and a cautious full-year outlook that overshadowed its quarterly revenue beat. While the 1-year total...",
        "pubDate": "2025-10-14T22:13:46Z",
        "displayTime": "2025-10-14T22:13:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-dxcm-valuation-focus-q2-221346549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-dxcm-valuation-focus-q2-221346549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T14:00:00+00:00",
    "headline": "2 Stocks Down 17% and 21% to Buy Right Now",
    "summary": "Both companies have faced recent challenges, but look likely to overcome them.",
    "url": "https://www.fool.com/investing/2025/10/14/2-stocks-down-15-and-18-to-buy-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f1850e04-36cd-320e-ab79-3a3c358720f8",
      "content": {
        "id": "f1850e04-36cd-320e-ab79-3a3c358720f8",
        "contentType": "STORY",
        "title": "2 Stocks Down 17% and 21% to Buy Right Now",
        "description": "",
        "summary": "Both companies have faced recent challenges, but look likely to overcome them.",
        "pubDate": "2025-10-14T14:00:00Z",
        "displayTime": "2025-10-14T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person using a CGM system.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nIMEUKFxgD7B61ElQsp0JQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4dExSqUPbHzM1hwPHxaN7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/14/2-stocks-down-15-and-18-to-buy-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-stocks-down-17-21-140000721.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T11:07:33+00:00",
    "headline": "Has DexCom’s Latest 14.5% Drop Created an Opportunity for Investors in 2025?",
    "summary": "If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last month, DexCom dropped 14.5%, extending a slide that’s seen the stock down 16.9% year-to-date and off more than 34% from its highs of the past few years. It’s not all bad news, though. Alongside shifting market dynamics around growth and risk, the most recent 1.7% weekly dip could be sparking new...",
    "url": "https://finance.yahoo.com/news/dexcom-latest-14-5-drop-110733879.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c3317432-e612-3c39-b7e5-56da446fe3bf",
      "content": {
        "id": "c3317432-e612-3c39-b7e5-56da446fe3bf",
        "contentType": "STORY",
        "title": "Has DexCom’s Latest 14.5% Drop Created an Opportunity for Investors in 2025?",
        "description": "",
        "summary": "If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last month, DexCom dropped 14.5%, extending a slide that’s seen the stock down 16.9% year-to-date and off more than 34% from its highs of the past few years. It’s not all bad news, though. Alongside shifting market dynamics around growth and risk, the most recent 1.7% weekly dip could be sparking new...",
        "pubDate": "2025-10-14T11:07:33Z",
        "displayTime": "2025-10-14T11:07:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-latest-14-5-drop-110733879.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-latest-14-5-drop-110733879.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T03:31:08+00:00",
    "headline": "Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment",
    "summary": "Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season.",
    "url": "https://finance.yahoo.com/news/q2-earnings-roundup-dexcom-nasdaq-033108152.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "5df84939-afec-3499-97d8-610debb7f5bf",
      "content": {
        "id": "5df84939-afec-3499-97d8-610debb7f5bf",
        "contentType": "STORY",
        "title": "Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment",
        "description": "",
        "summary": "Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season.",
        "pubDate": "2025-10-14T03:31:08Z",
        "displayTime": "2025-10-14T03:31:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DXCM Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/udhbB0cHnVJO4WPtUvUsrA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OPrVhYWO.9SMzT6mgJAbDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/q2-earnings-roundup-dexcom-nasdaq-033108152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/q2-earnings-roundup-dexcom-nasdaq-033108152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]